Skip to main content
Clinical Trials/ISRCTN13646289
ISRCTN13646289
Completed
Not Applicable

An Investigational Study of the Effectiveness and Safety of the LigaSure™ Tissue Fusion System in Hysterectomy via Transvaginal Natural Orifice Transluminal Endoscopic Surgery (NOTES)

Covidien Private Limited0 sites72 target enrollmentDecember 21, 2016

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Transvaginal hysterectomy
Sponsor
Covidien Private Limited
Enrollment
72
Status
Completed
Last Updated
9 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
December 21, 2016
End Date
TBD
Last Updated
9 years ago
Study Type
Interventional
Sex
Female

Investigators

Eligibility Criteria

Inclusion Criteria

  • 1\. Female patients 35 years of age or older
  • 2\. Scheduled to undergo a transvaginal NOTES hysterectomy
  • 3\. Willing to provide informed consent

Exclusion Criteria

  • 1\. Multiple abdominal surgery, except caesarean section
  • 2\. History of coagulation disorder
  • 3\. History of liver and renal dysfunction within 6 months prior to inclusion into the study
  • 4\. Severe inflammatory diseases
  • 5\. Malignancy
  • 6\. Electrosurgery contraindicated
  • 7\. Hypersensitivity to or unable to tolerate general anesthesia or analgesic
  • 8\. Those participating any clinical trials within 3 months prior to the intervention
  • 9\. Not suitable for surgical intervention at the discretion of the investigator

Outcomes

Primary Outcomes

Not specified

Similar Trials